O-Hemi-succinate of propranolol

摘要

This invention is directed to novel compounds having beta -adrenergic blocking activity. The compounds are represented by the following structural formula: <IMAGE> wherein R1 is hydrogen or methyl, R2 is hydrogen or lower alkyl and their pharmaceutically acceptable salts.